WallStSmart
ALHC

Alignment Healthcare LLC

NASDAQ: ALHC · HEALTHCARE · HEALTHCARE PLANS

$17.16
+1.99% today

Updated 2026-06-05

Market cap
$4.08B
P/E ratio
197.50
P/S ratio
0.96x
EPS (TTM)
$0.10
Dividend yield
52W range
$12 – $24
Volume
5.2M

Alignment Healthcare LLC (ALHC) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item2019202020212022202320242025
Total assets$193.44M$338.50M$630.89M$633.86M$591.88M$782.06M$1.07B
Cash & equivalents$86.48M$207.31M$466.60M$409.55M$202.90M$432.86M$577.94M
Current assets$127.35M$264.68M$552.86M$544.55M$483.54M$661.64M$831.14M
Total liabilities$272.15M$307.89M$324.84M$394.56M$433.81M$681.11M$886.51M
Current liabilities$130.26M$153.45M$167.25M$229.96M$263.02M$351.85M$476.53M
Long-term debt$137.96M$144.17M$150.62M$160.90M$161.81M$321.43M$323.18M
Shareholder equity$-78.71M$30.61M$306.04M$238.13M$156.95M$99.85M$179.28M
Retained earnings$-78.71M$-379.57M$-582.69M$-732.24M$-880.26M$-1.01B$-1.01B
Accounts receivable$35.63M$40.14M$58.51M$92.89M$119.75M$153.90M$253.21M
Inventory
Goodwill$29.30M$29.30M$29.30M$34.81M$34.83M$34.83M$32.06M

Frequently asked questions

What is Alignment Healthcare LLC's revenue?

Alignment Healthcare LLC's trailing twelve-month revenue is $4.26B. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is ALHC?

In its most recent fiscal year, ALHC ran a gross margin of 12.37%, an operating margin of 0.37%, and a net margin of -0.02%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does ALHC generate?

ALHC produced $113.15M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is ALHC's balance sheet healthy?

ALHC holds $577.94M in cash and equivalents against $323.18M in long-term debt, on $179.28M of shareholder equity. Cash on hand exceeds long-term debt, so the balance sheet adds little financial risk to the thesis.